EllenRx® Prior Authorization Card

Dupixent (dupilumab)

FDA-approved uses
Atopic Dermatitis, Asthma, CRSwNP, EoE, Prurigo Nodularis, COPD, Chronic hives (CSU), Bullous pemphigoid, Allergic fungal rhinosinusitis
How it's given
Injection under the skin
Typical first approval
First approvals often last 4 to 12 months, depending on the plan and condition.
Sources checked
2026-11-10

What payers commonly require

  • For eczema: tried prescription skin creams firstPlans want to see that prescription creams or ointments did not work well enough, or could not be used, before approving Dupixent.Source: Aetna, Cigna, UnitedHealthcare, Anthem/Elevance, FDA label
  • For asthma: blood test showing high eosinophilsPlans ask for a blood test of eosinophils (a type of white blood cell), often at least 150 cells per microliter, unless you need daily steroid pills for asthma.Source: Aetna, Cigna, UnitedHealthcare, Anthem/Elevance, FDA label
  • For asthma: still uncontrolled on daily inhalersPlans want proof your asthma stayed uncontrolled even while using a steroid inhaler plus another controller medicine.Source: Aetna, Cigna, UnitedHealthcare, Anthem/Elevance
  • Keep using your usual inhaler or nasal sprayDupixent is an add-on for asthma, COPD, and nasal polyps, so plans expect you to keep taking your regular daily medicine with it.Source: Aetna, Cigna, UnitedHealthcare, Anthem/Elevance, FDA label
  • Prescribed by or with a specialistPlans usually want a specialist for your condition, such as a skin, allergy, lung, or stomach doctor, to prescribe or advise.Source: Aetna, Cigna, UnitedHealthcare
  • Not combined with similar biologic drugsPlans usually will not pay for Dupixent together with another biologic shot used for the same condition.Source: Cigna, UnitedHealthcare, Anthem/Elevance

Each plan has its own policy. Check the patient's plan before submitting.

Letter of medical necessity

Address each item above in the letter and attach the chart notes that show it: the diagnosis, prior treatments with dates and results, and any required test results.

Draft a letter with Ellen

Patients: see the Dupixent patient page.

Sources: FDA label (DailyMed), Aetna (Policy Dupixent SGM 1690-A P2026b, page dated October 13, 2026), Anthem/Elevance (Publish date 09/10/2025; last review 08/15/2025), Cigna (Effective 06/15/2026), UnitedHealthcare (Effective 9/1/2026).

Not medical advice. For educational use by clinic staff. Ellen does not diagnose conditions or recommend treatments. Payer policies change often; confirm with the patient's plan.